Laughter Therapy and Mindfulness Practices
NCT05634343, Not applicable, Completed, Nagihan Koroglu Kaba
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Laughter Therapy and Mindfulness Practices | ClinicalTrials.gov |
| NCT number | NCT05634343 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 117 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Nagihan Koroglu Kaba | ClinicalTrials.gov |
| Conditions | Nurse's Role | ClinicalTrials.gov |
| Interventions | experimental group 1, experimantal group 2 | ClinicalTrials.gov |
| First posted | 2022-12-02 | ClinicalTrials.gov |
| Last updated | 2024-08-21 | ClinicalTrials.gov |
Registered outcomes 17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Personal Information Form | First day | This form developed by the researcher consists of six questions about the characteristics of nurses. | ClinicalTrials.gov |
| Primary | Chalder Fatigue Scale | First day | The scale was developed in 1993 to measure the severity of fatigue. The scale has two sub-dimensions (physical and mental) and consists of 11 items. The total fatigue score is obtained by summing the scores of all items. Higher scores indicate greater severity of fatigue. | ClinicalTrials.gov |
| Primary | Computer-Based Sustainable Attention Test | First day | Developed in 2006, the test measures sustained attention at three levels: easy, medium and difficult. A minimum of 0 and a maximum of 10 are taken from each level. An increase in the test score indicates an increase in the level of sustained attention. | ClinicalTrials.gov |
| Primary | Stroop Test Çapa Form | First day | The Stroop form developed by Weintraub in 2000 was adapted to Turkish by Emek Savaş et al. The test is used to determine the selective attention and reaction time of individuals. In the test, there are two stimulus cards and a total of 60 items placed on each card in the order of 6 x 10. The first card contains small rectangles of red, green and blue, while the second card has color names written in mismatched ink colors. The Stroop test is one of the most frequently used tests in neuropsychological evaluation. The fact that it can be applied to people of all age groups in a short time increases the preferability of the test. | ClinicalTrials.gov |
| Primary | Individual Job Performance Scale | First day | The scale developed by Koopmans et al. in 2013 measures employee performance in three dimensions (task, contextual, counterproductive behaviour). The scale has 14 items and is a five-point Likert scale. | ClinicalTrials.gov |
| Secondary | Chalder Fatigue Scale | At the end of the 1st month | The scale was developed in 1993 to measure the severity of fatigue. The scale has two sub-dimensions (physical and mental) and consists of 11 items. The total fatigue score is obtained by summing the scores of all items. Higher scores indicate greater severity of fatigue. | ClinicalTrials.gov |
| Secondary | Computer-Based Sustainable Attention Test | At the end of the 1st month | Developed in 2006, the test measures sustained attention at three levels: easy, medium and difficult. A minimum of 0 and a maximum of 10 are taken from each level. An increase in the test score indicates an increase in the level of sustained attention. | ClinicalTrials.gov |
| Secondary | Stroop Test Çapa Form | At the end of the 1st month | The Stroop form developed by Weintraub in 2000 was adapted to Turkish by Emek Savaş et al. The test is used to determine the selective attention and reaction time of individuals. In the test, there are two stimulus cards and a total of 60 items placed on each card in the order of 6 x 10. The first card contains small rectangles of red, green and blue, while the second card has color names written in mismatched ink colors. The Stroop test is one of the most frequently used tests in neuropsychological evaluation. The fact that it can be applied to people of all age groups in a short time increases the preferability of the test. | ClinicalTrials.gov |
| Secondary | Individual Job Performance Scale | At the end of the 1st month | The scale developed by Koopmans et al. in 2013 measures employee performance in three dimensions (task, contextual, counterproductive behaviour). The scale has 14 items and is a five-point Likert scale. | ClinicalTrials.gov |
| Secondary | Chalder Fatigue Scale | At the end of the 2st month | The scale was developed in 1993 to measure the severity of fatigue. The scale has two sub-dimensions (physical and mental) and consists of 11 items. The total fatigue score is obtained by summing the scores of all items. Higher scores indicate greater severity of fatigue. | ClinicalTrials.gov |
| Secondary | Computer-Based Sustainable Attention Test | At the end of the 2st month | Developed in 2006, the test measures sustained attention at three levels: easy, medium and difficult. A minimum of 0 and a maximum of 10 are taken from each level. An increase in the test score indicates an increase in the level of sustained attention. | ClinicalTrials.gov |
| Secondary | Stroop Test Çapa Form | At the end of the 2st month | The Stroop form developed by Weintraub in 2000 was adapted to Turkish by Emek Savaş et al. The test is used to determine the selective attention and reaction time of individuals. In the test, there are two stimulus cards and a total of 60 items placed on each card in the order of 6 x 10. The first card contains small rectangles of red, green and blue, while the second card has color names written in mismatched ink colors. The Stroop test is one of the most frequently used tests in neuropsychological evaluation. The fact that it can be applied to people of all age groups in a short time increases the preferability of the test. | ClinicalTrials.gov |
| Secondary | Individual Job Performance Scale | At the end of the 2st month | The scale developed by Koopmans et al. in 2013 measures employee performance in three dimensions (task, contextual, counterproductive behaviour). The scale has 14 items and is a five-point Likert scale. | ClinicalTrials.gov |
| Secondary | Chalder Fatigue Scale | At the end of the 3st month | The scale was developed in 1993 to measure the severity of fatigue. The scale has two sub-dimensions (physical and mental) and consists of 11 items. The total fatigue score is obtained by summing the scores of all items. Higher scores indicate greater severity of fatigue. | ClinicalTrials.gov |
| Secondary | Computer-Based Sustainable Attention Test | At the end of the 3st month | Developed in 2006, the test measures sustained attention at three levels: easy, medium and difficult. A minimum of 0 and a maximum of 10 are taken from each level. An increase in the test score indicates an increase in the level of sustained attention. | ClinicalTrials.gov |
| Secondary | Stroop Test Çapa Form | At the end of the 3st month | The Stroop form developed by Weintraub in 2000 was adapted to Turkish by Emek Savaş et al. The test is used to determine the selective attention and reaction time of individuals. In the test, there are two stimulus cards and a total of 60 items placed on each card in the order of 6 x 10. The first card contains small rectangles of red, green and blue, while the second card has color names written in mismatched ink colors. The Stroop test is one of the most frequently used tests in neuropsychological evaluation. The fact that it can be applied to people of all age groups in a short time increases the preferability of the test. | ClinicalTrials.gov |
| Secondary | Individual Job Performance Scale | At the end of the 3st month | The scale developed by Koopmans et al. in 2013 measures employee performance in three dimensions (task, contextual, counterproductive behaviour). The scale has 14 items and is a five-point Likert scale. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 41118502 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)